- Home
- PRME vs EMD Comparison
PRME vs EMD Comparison
Compare PRME & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- EMD
- Stock Information
- Founded
- PRME 2019
- EMD 2003
- Country
- PRME United States
- EMD United States
- Employees
- PRME N/A
- EMD N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- EMD Finance/Investors Services
- Sector
- PRME Health Care
- EMD Finance
- Exchange
- PRME Nasdaq
- EMD Nasdaq
- Market Cap
- PRME 693.5M
- EMD 601.7M
- IPO Year
- PRME 2022
- EMD N/A
- Fundamental
- Price
- PRME $5.10
- EMD $10.51
- Analyst Decision
- PRME Buy
- EMD
- Analyst Count
- PRME 6
- EMD 0
- Target Price
- PRME $8.88
- EMD N/A
- AVG Volume (30 Days)
- PRME 4.0M
- EMD 248.5K
- Earning Date
- PRME 11-11-2025
- EMD 01-01-0001
- Dividend Yield
- PRME N/A
- EMD 10.25%
- EPS Growth
- PRME N/A
- EMD N/A
- EPS
- PRME N/A
- EMD N/A
- Revenue
- PRME $4,961,000.00
- EMD N/A
- Revenue This Year
- PRME $179.58
- EMD N/A
- Revenue Next Year
- PRME N/A
- EMD N/A
- P/E Ratio
- PRME N/A
- EMD N/A
- Revenue Growth
- PRME 739.42
- EMD N/A
- 52 Week Low
- PRME $1.11
- EMD $7.85
- 52 Week High
- PRME $6.94
- EMD $9.55
- Technical
- Relative Strength Index (RSI)
- PRME 46.40
- EMD 60.07
- Support Level
- PRME $5.39
- EMD $10.00
- Resistance Level
- PRME $6.30
- EMD $10.68
- Average True Range (ATR)
- PRME 0.66
- EMD 0.15
- MACD
- PRME -0.15
- EMD 0.03
- Stochastic Oscillator
- PRME 1.60
- EMD 75.29
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.